Adaptive Biotechnologies (NASDAQ:ADPT) executives said the company delivered “remarkable” performance in 2025, driven by ...

The Phase 1 clinical trial, STRIKE-001 (NCT07103018), is a multi-center, open-label dose escalation of KTX-2001 monotherapy (Part A) and in combination with darolutamide, an oral, nonsteroidal ...

Targeted therapies, bispecifics, and CAR T-cell therapies are giving patients with multiple myeloma hope for long-term remission or a potential cure.

Nocturnal symptoms and musculoskeletal pain are filtered through relapse fear, driving repetitive interpretation of ...

According to him, the results arrived a week later with words he says he will never forget.“The crucial sentence was that the images indicated a high possibility of malignant activity. In a nutshell, ...

The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of ...

(Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 clinical study evaluating ...

Bristol-Myers Squibb (BMY) stock gains after the company beat with its Q4 2025 financials and 2026 outlook as its growth portfolio outperforms. Read more here.

Data-driven analysis shows outpatient stem-cell mobilisation can reduce hospital bed use while maintaining safety, supported ...

When Ken did not show up for a 4 PM show that featured Shelly Berg, one of his closest friends and colleagues, you knew that ...

However, with these recommendations, patients with advanced blood cancers use hospice much less than patients with solid tumors. These advanced cancers include leukemia, lymphoma and multiple myeloma, ...

Jazz bandleader Ken Peplowski has died at 66 after collapsing aboard The Jazz Cruise, just hours before a scheduled performance.